Search

Establishes first integrated health system in Nevada. The Nevada System of Higher Education (NSHE) Board of Regents voted today at its monthly board meeting to approve an affiliation agreement between the University of Nevada, Reno School of Medicine (UNR Med) and Renown Health that will establish the first fully integrated health system in Nevada.   The Board of Regents approval of the collaboration between Nevada's oldest medical school and one of its largest non-profit health care organizations comes after Nevada Governor Steve Sisolak signed Senate Bill 342 into law. The bill authorizes the NSHE Board of Regents to enter into an agreement to affiliate with a publicly or privately owned medical facility or related entity, whether for profit or not for profit, to further promote and enhance a medical education or health education program at a university.  Nearly a year ago, UNR Med and Renown Health announced an intent to affiliate and create an enhanced health care network with increased access to clinical care, and expanded clinical training and clinical research programs. In September 2020, the Board of Regents unanimously endorsed a Letter of Intent between the two organizations, which advanced a period of due diligence to further define the relationship. In addition, the Renown Board of Trustees unanimously approved the agreement. “Thank you to the Board of Regents and Chancellor Rose for supporting UNR Med and Renown Health in this collaborative and generational partnership that will have historical impacts on health care delivery, clinical research development, and training for health care professionals in our state and our community,” says University of Nevada, Reno President Brian Sandoval. “This affiliation will help address Nevada’s access to health care and medical education challenges in new and innovative ways that proactively support the health and wellness of all.” The affiliation agreement details a 50-year commitment for combining the clinical practice, clinical teaching and clinical research programs of both institutions, including descriptions of purpose, structure, governance, funds flow, joint leadership roles and faculty positions, operational management, mission and culture. Renown Health and UNR Med aim to accomplish key strategic goals, including: Improving access to care, including creating new clinical services not currently available in the community; Creating new clinical training programs for UNR Med residents and medical students; Increasing UNR Med’s student class size, which currently accommodates 70 students per medical class; and Providing increased patient access to clinical trials and expanding research and employment capabilities. Like many medical schools and health care systems across the nation, UNR Med and Renown Health have collaborated for decades to advance a mutual commitment to improving the health of the community. Since mid-2020, the organizations have been exploring formalizing a high-level clinical integration.  “I appreciate and am so pleased that the Nevada System of Higher Education Board of Regents, Governor Sisolak and the legislature have provided such incredible support for the affiliation of University of Nevada, Reno School of Medicine and Renown Health. We are excited to further our mission of supporting the health and healthcare of the people and communities we serve in local urban and rural communities, across our state and our nation, says Tony Slonim, MD, DrPH, President & CEO of Renown Health. “With this new level of integration, we will be able to drive innovation, research, medical education, grant funding for public health, clinical trials and integrate our medical practices to improve access and affordability of care. Together, we are excited to create a healthier Nevada.”  “We are creating an integrated health system that brings together three complimentary initiatives - patient care, research and medical education - and melds them into a single mission, each enhancing the others synergistically, while benefitting the community and the state,” says UNR Med Dean Thomas L. Schwenk, M.D.  “The affiliation with Renown Health enhances and leverages the fundamental missions of UNR Med as a state-funded, accredited public medical school governed by the Nevada System of Higher Education so as to remain accessible to Nevada residents and provide opportunities to serve the state in new and expanded ways. The affiliation helps both of our institutions contribute to outstanding health care in Nevada.” This is an affiliation between a 159-year old health care provider, the state’s original land grant university and the state’s oldest medical school. Over the last five decades, UNR Med has educated more than 3,900 physicians with over 30% percent practicing in Nevada, increasing access to care for Nevadans across the state. Equally rooted in the community, Renown’s long legacy of service started in 1862 as a county hospital, Washoe Medical Center. Now, Renown Health, a charitable, not-for-profit organization, serves the community by providing care through hospitals, outpatient medical offices, institutes and a health insurance plan, Hometown Health.   UNR Med Public Relations Julie Ardito, APR M: 775-846-8445 E: jardito@med.unr.edu   About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org. About University of Nevada, Reno School of Medicine The University of Nevada, Reno School of Medicine, Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu.

Read More About Nevada System of Higher Education Board of Regents Approve Renown Health and University of Nevada, Reno School of Medicine Affiliation Agreement

A coalition of 60 top hospitals and healthcare institutions have joined forces in a nationwide campaign to encourage adults to get vaccinated against COVID-19. Led by Cleveland Clinic and Mayo Clinic, the campaign "Get the Vaccine to Save Lives" is designed to reassure the public that vaccines are safe, effective and necessary to achieve herd immunity and return to normal activities. "We're asking people to talk to their healthcare providers if they have questions and then get vaccinated," says Gianrico Farrugia, M.D., Mayo Clinic's president and CEO. "The vaccine is our strongest asset to end the pandemic, and I urge everyone who is eligible to get whichever vaccine you're first offered to save lives." The campaign hopes to reach adults who are hesitant to receive a vaccine, including racial and minority ethnic groups and people living in rural communities. According to a Kaiser Family Foundation survey published March 30, 17% of the public say they will take a wait-and-see approach before getting it themselves, and another 20% say they will never get a vaccine or will only get it if required to do so for work, school or other activities. This leaves a significant portion of the population at risk of going unvaccinated.  The nationwide campaign includes print and digital advertising, media outreach, social media, an awareness video and an informational website. "The COVID-19 vaccine is safe and highly effective and offers our best hope for beating the disease," said Tom Mihaljevic, M.D., Cleveland Clinic's CEO and president. "We all want to see a return to our pre-COVID routines, when we can once again gather safely with family and friends. To reach that goal, we must improve vaccination rates to achieve herd immunity. Please sign up today because we are all in this together." With vaccine distribution underway, the campaign aims to help Americans feel safe and confident about receiving a vaccine. To achieve herd immunity and help end the pandemic, leading health officials say at least 75% of the population needs to receive a vaccine. Herd immunity occurs when a large portion of a community becomes immune to a disease, making the spread of disease from person to person unlikely. As a result, the whole community becomes protected — not just those who have been vaccinated. In addition to Mayo Clinic and Cleveland Clinic, 58 other leading U.S. healthcare institutions have joined the campaign. They include: Advent Health Adventist Health Allegheny Health Network Ann & Robert H. Lurie Children's Hospital of Chicago Arizona Medical Association Ascension St. Vincent's Atrium Health Banner Health Baptist Health South Florida Baylor Scott & White Health Beaumont Health BJC HealthCare Brooks Rehabilitation Broward Health Centura Health Einstein Healthcare Network Emory Healthcare Essentia Health Hackensack Meridian Honor Health Intermountain Healthcare    Lee Health Mass General Brigham McLaren St. Luke's MedStar Health Memorial Healthcare System Memorial Sloan Kettering Cancer Center Mercy Health Michigan Medicine Monument Health NCH Healthcare System Nicklaus Children's Health System North Shore University Health System Northwestern Medicine Norton Healthcare Peace Health Piedmont Healthcare ProMedica Renown Health Rush University Medical Center Chicago Southwestern Health Resources Spectrum Health Summit Health Texas Health          The Ohio State University Wexner Medical Center and The James Cancer Hospital The Toledo Clinic The University of Texas MD Anderson Cancer Center Theda Care UC Health (Cincinnati) UNC Health University Hospitals University of Chicago Medicine University of Iowa Health Care University of Toledo Medical Center UT Southwestern Medical Center Virtua Health Well Span Health Yale New Haven Health   More than 209 million doses of COVID-19 vaccine have been administered and 50% of the population age 18 and over has received at least one vaccine dose in the U.S. through April 18, according to the Centers for Disease Control and Prevention. COVID-19 vaccines were evaluated in tens of thousands of participants in clinical trials. The vaccines met the Food and Drug Administration's rigorous scientific standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization. Ethos Creative Group of Burlington, North Carolina, created the campaign and donated their services. Facebook, iHeartRadio, Spectrum Reach, The New York Times, The Washington Post, USA Today, and YouTube also provided complimentary resources. For more information about the campaign, visit ourshot2savelives.org     About Renown Health  Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Leading U.S. Hospitals Team Up To Promote COVID-19 Vaccine

Three-day medical education conference advances research, education, prevention and treatment. Physicians and medical professionals from throughout the Mountain West will soon be convening in Lake Tahoe to explore emerging treatments, the most recent advances and new clinical guidelines for the diagnosis, treatment and prevention of cardiovascular disease, diabetes mellitus, stroke and heart disease. Hosted by Renown's Institute for Heart & Vascular Health and the Nevada Academy of Family Physicians, the three-day Trends in Cardiovascular Medicine conference will bring together national experts to explore challenges and solutions to cardiovascular diseases, the leading cause of death globally, taking an estimated 17.9 million lives each year. "Our mission is to advance health in America. As Nevada's first integrated health system, with our University of Nevada, Reno School of Medicine affiliation, we are advancing health and health care through world-class medical education, clinical research and patient care for our community, our state and our nation," says Anthony D. Slonim, MD, DrPH, President & CEO, Renown Health. "And, we have so much work to do. In 2019, 9.5% of Nevadans reported being told by a health professional that they had angina or coronary heart disease; which is significantly above the national average of 8.4%. As public health and health care providers, we can do more to encourage people to adopt healthy lifestyle habits to keep their heart healthy and help prevent heart disease through the Healthy Nevada Project®, where people can understand their genetic risks at no-cost." "The driving force behind this collaborative event is the shared missions of all our organizations, across the country, to advance progress in cardiovascular research, education, prevention and treatment," says Jayson Morgan, MD, FACC, Director Cardiovascular Services at Renown. "We will be joined by colleagues from Johns Hopkins, Cedars-Sinai, Scripps, University of New Mexico Health Sciences, University of Utah, Medical College of Wisconsin, the Metabolic Institute of America and locally- with experts from Renown's Institute for Heart & Vascular Health/UNR Med, St. Mary's and Barton Health - to discuss contemporary trends in providing excellent cardiovascular care and prevention." New research will be presented each day, including: “Vaping and Electronic Cigarettes – The Hidden Epidemic: What the Clinician Needs to Know” Michael J. Blaha, MD, MPH, FACC, Professor of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Director of Clinical Research, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD “Optimizing Glycemic Control in the Inpatient Setting” Kendall M. Rogers, MD, CPE, FACP, SFHM, Professor, Department of Internal Medicine, University of New Mexico School of Medicine, Chief, Division of Hospital Medicine, Department of Internal Medicine, University of New Mexico Health Sciences, Albuquerque, NM “Perioperative Medicine Update”                                                                                                                                                                                             Barbara A. Slawski, MD, MS, SFHM Professor of Medicine & Orthopaedic Surgery, Chief, Section of Hospital Medicine, Division of General Internal Medicine, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI “Understanding hATTR Amyloidosis: Clinical Presentation and Treatment Landscape” Jignesh K. Patel, MD, PhD, FACC, FRCP, FAST, FAHA, Clinical Professor of Medicine, Medical Director, Heart Transplant Program, Director, Cardiac Amyloid Program, Director, Heart Transplant Research, Cedars-Sinai Medical Center, Los Angeles, CA “Coronary Artery Calcium in 2021: Guideline-Endorsed and Ready for Prime Time” “The Evolving Landscape of Obesity Management – A 2021 Update” Ken Fujioka, MD, Director of the Center for Weight Management, Director of the Nutrition and Metabolic Research Center, Scripps Clinic, Department of Diabetes and Endocrine, San Diego, CA “The Evolving Landscape of Obesity Management – A 2021 Update” Ken Fujioka, MD, Director of the Center for Weight Management, Director of the Nutrition and Metabolic Research Center, Scripps Clinic, Department of Diabetes and Endocrine, San Diego, CA “Management of Atrial Fibrillation: Where We Are; Where We Are Headed” Matthew A. Cain, MD, Electrophysiologist, Renown Institute for Heart & Vascular Health, Renown Medical Group, Reno, NV "The Story of a Murmur” Abhilash Akinapelli, MD, Cardiac Valve & TAVR Program Director, Renown Institute for Heart & Vascular Health, Renown Medical Group, Reno, NV "Update on the Cardiovascular Effects of COVID-19” Siddharth Singh, MD, Assistant Director, Echo Fellowship Training Program, Smidt Heart Institute, Cedars-Sinai, Los Angeles, CA “Antibiotic Stewardship: How to Improve Our Prescribing for Now and Later”                                                                                                                            Valerie M. Vaughn, MD, MSc, FACP, FHM, Assistant Professor, Instructional Track Director of Hospital Medicine Research, Division of General Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT "Emerging Trends in the Clinical Management of VTE”                                                                                                                                                                Victor F. Tapson, MD, FCCP, FRCP, Director, Clinical Research for the Women’s Guild Lung Institute, Director, Venous Thromboembolism & Pulmonary Vascular Disease Research Program, Associate Director, Pulmonary and Critical Care Division, Cedars-Sinai Medical Center, Los Angeles, CA “Contemporary Approach to the Management of Diabetes as a Cardiovascular Disease”                                                                                               Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE, Medical Director & Principal Investigator, Metabolic Institute of America, Tarzana, CA The Arthur J Lurie, MD Memorial Dinner and Keynote Presentation, sponsored by the charitable Renown Foundation and the Lurie Family, is an evening ceremony to honor and memorialize the devotion and innovation of the lake Dr. Arthur J. Lurie, who personified humanitarian, medical and community service. Dr. Lurie devoted modernized heart surgery and was steadfast in his commitment to introduce new and groundbreaking techniques cardiovascular techniques to Nevada. He promoted and inspired life-changing research and advancements in heart surgery, as well as cancer research, until his passing in 1996. Medical professionals are invited to attend the 31st Annual Trends in Cardiovascular Medicine conference will take place at the Resort at Squaw Creek in Olympic Valley, CA from Friday, Nov. 5 through Sunday, Nov. 7, 2021. Those interested in registering or learning more may visit www.renown.org/trends. The clinical team at Renown Institute for Heart and Vascular Health is the recipient of a number of national awards for outstanding clinical care and service, including: In U.S. News and World Report Best Hospital rankings for 2021, Renown Regional Medical Center - #1 in the State of Nevada for 2021. No other hospital in Nevada earned recognition from U.S. News. Renown Regional Medical Center is High Performing, its highest rating possible, for Heart Failure and Chronic Obstructive Pulmonary Disease. Awarded by the American College of Surgeons for the Renown Regional earned America's 100 Best Hospitals for Critical Care Award (2021) for Superior clinical outcomes in treating pulmonary embolism, respiratory system failure, sepsis, and diabetic emergencies. Regional also earned the Pulmonary Care Excellence Award™ (2021), for superior outcomes. Designated Level II Trauma Center. For the 30th year, Renown Regional Medical Center is northern Nevada's only designated level II trauma center. Renown Regional awarded The Get with the Guidelines - Heart Failure Gold Plus Quality Achievement award for continually ensuring heart failure patients receive the most appropriate treatment according to nationally recognized, research-based guidelines, as well as AHA's mission: Lifeline Gold Receiving honor for the treatment of patients who suffer severe heart attacks. American College of Cardiology's NCDR Chest Pain-MI Registry Platinum Performance Achievement Award. Renown Regional Medical Center is one of only 225 hospitals nationwide to receive the honor. The award recognizes Renown's success in implementing a higher standard of care for heart attack patients and signifies that Renown has reached an aggressive goal of treating these patients to standard levels of care as outlined by the American College of Cardiology/American Heart Association clinical guidelines and recommendations.  To make an appointment with a provider at Renown's Institute for Heart and Vascular Health, request that your primary care provider make a referral. For more information on Renown's Institute for Heart and Vascular Health, visit renown.org/Health-Services/Heart-Care.     About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. In U.S. News and World Report Best Hospital rankings, Renown Regional Medical Center was listed #1 in the State of Nevada. Renown has a long tradition and commitment to improve the care and the health of our community. For more information, visit renown.org.

Read More About Leading Experts Convene in Tahoe to Focus on Scientific Advancements and the Prevention of Cardiovascular Disease, the #1 Cause of Death Globally

Experienced physician, researcher, mentor, and educator to lead obstetrics and gynecology department at the University of Nevada Reno School of Medicine (UNR Med) and Renown Health. James M. Alexander, M.D., an experienced leader and clinician in OB/GYN, is regularly in the room at the beginning of something new, so it’s fitting that he is one of the first jointly appointed senior clinical leaders of Nevada’s first integrated health system. As the chair of the department of Obstetrics and Gynecology at the University of Nevada, Reno School of Medicine (UNR Med) and Renown Health, Dr. Alexander will lead the medical and surgical services, academic advancement, research, and teaching programs for the healthcare system. A 50-year affiliation agreement signed in 2021 solidified the integration of the UNR Med, Nevada’s first medical school, with Renown, northern Nevada’s most extensive health system. “The affiliation offers a remarkable opportunity to advance health and health care through medical education, clinical research, and patient care for our community and our state,” Dr. Alexander said. “By integrating our teaching, research, and patient care, we can make a difference for women and children in Nevada and beyond.” He is one of the first of several planned joint-chair hires for UNR Med and Renown. “Dr. Alexander is a dedicated obstetrician and gynecologist who takes great pride in his work as a researcher and mentor,” said Melissa Piasecki, M.D., UNR Med Acting Dean, and Renown Chief Academic Officer. “He has a deep commitment to improving women's health and fostering the careers of future physicians in this specialty. Our school of medicine and health system are very fortunate to have recruited Dr. Alexander and will benefit from the growth of clinical services, medical education and clinical research in obstetrics and gynecology under his direction.”” A 1991 graduate of the University of Texas at Houston, Dr. Alexander most recently chaired the OB/GYN department at the Kirk Kerkorian School of Medicine at UNLV. He completed his residency at the University of Alabama at Birmingham and a fellowship in Maternal Fetal Medicine at the University of Texas Southwestern. He was recruited to the faculty at UTSW after finishing his fellowship and held several leadership positions there, including chief of the obstetrics service. Dr. Alexander established himself as a clinical investigator at UTSW and served as co-investigator on several studies conducted by the Maternal Fetal Medicine Units Network of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. He has published widely on obstetrics and maternal fetal medicine topics, including cesarean delivery, prematurity, obstetric complications, labor management, and obstetric anesthesia. He has contributed to the leading textbook on obstetrics, “Williams Obstetrics.” Following his tenure at UTSW, Dr. Alexander held the positions of division director of maternal fetal medicine at the University of Arkansas for Medical Sciences as well as director of maternal fetal medicine and obstetrics at the Billings Clinic. He is board certified in Obstetrics and Maternal Fetal Medicine and currently serves as an examiner for the American Board of Obstetrics and Gynecology. “Shaping the future of healthcare in our state has never been more important than it is now,” said Rahul Mediwala, M.D., Chief Medical Officer of the Health Services Division at Renown Health. “I do not doubt that Dr. Alexander will apply his skills, enthusiasm, and guiding leadership to improve our community's health through increased access to care, innovative health care delivery, and expanding clinical research.”     About University of Nevada, Reno School of Medicine The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu.   About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About James M. Alexander M.D., Named First OB/GYN Chair for Nevada's First Integrated Health System

Freenome, a privately held biotech company announced today that Renown Health has joined as a partner for the Sanderson Study, Freenome’s study of its multiomics platform, in combination with real-world data to detect multiple cancers. The study encompasses both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition, the Sanderson Study will build the necessary infrastructure to bridge the gap between clinical research and day-to-day clinical impact. Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to detect cancer in its earliest stages using a standard blood draw. “We are delighted to partner with Freenome to launch this far-reaching trial which has transformative potential,” said Lee Schwartzberg, MD, medical oncology section chief and the principal investigator for the Sanderson Study at Renown. “Studying the impact of merging real-world information from patients with multiomics technology holds the promise of a truly personalized approach to early detection of cancer.” Renown Health has multiple clinical trials currently available to patients in northern Nevada across a variety of specialties, including oncology, cardiology, neurology, pediatrics, and pulmonology. Cancer is the second-leading cause of death in the Silver State, claiming the lives of more than 5,400 Nevadans each year. This number has increased since the last five-year plan estimates of 4,400 deaths per year.1 Promoting research to improve cancer prevention, detection, diagnosis and treatment is a key goal outlined in the Nevada Cancer Plan, 2021-2025, a framework developed by the Nevada Cancer Coalition in partnership with the Nevada Department of Health and Human Services. Access and participation in clinical trials is a key component of the plan, which, Renown says, makes participation in the Sanderson Study even more significant. “At the inception of the William N. Pennington Cancer Institute, we committed to not only provide the very best care possible to our community, but to also help improve outcomes through participation in research,” said Max Coppes, MD, PhD, MBA, cancer center director of the William N. Pennington Cancer Institute. “The research collaboration with Freenome has the potential to make a dream come true: Finding cancer early when it’s most treatable.” The Sanderson Study will enroll approximately 8,000 patients through Freenome’s clinical study partner network and numerous regional health systems across the United States. “Renown is committed to making a difference in the health and well-being of patients in communities across the state of Nevada, and that includes access to innovative research,” said Lance Baldo, MD, chief medical officer at Freenome. “The combination of real-world data and multiomics is poised to transform the landscape of early cancer detection.” Freenome’s clinical studies are named for employees’ loved ones who fought cancer. This study honors Tim Sanderson, the loving father of a Freenome engineer. For residents of Nevada interested in participating in the Sanderson Study, contact the William N. Pennington Cancer Institute clinical research coordinators at renown-crd@renown.org. Click here for more information on the Sanderson Study. About Freenome Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California. About Renown Health’s William N. Pennington Cancer Institute The William N. Pennington Cancer Research Institute provides comprehensive multidisciplinary cancer care for the northern Nevada community, helps educate the next generation of healthcare providers, and works to improve treatments and outcomes through active participation in research. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.

Read More About Freenome Adds Renown Health As Partner for The Sanderson Study